The potential of mRNA vaccines was established during the COVID-19 pandemic. Now, a new wave of candidates could soon hit the ...

Interim data from the Phase I dose escalation part of the mRNA cancer immunotherapy (mRNA-4359), show promise in patients ...

The Florida Department of Health, run by Surgeon General Dr. Joseph Ladapo, just released guidance on COVID-19 vaccines based ...

Moderna shares have dropped by over -41.67% since I last covered them over the summer. See why I continue to rate MRNA stock ...

Did you know that the COVID-19 mRNA vaccination is safe and beneficial for children and adults with sickle cell disease?

RNA vaccines have gained widespread attention for their crucial role in fighting the COVID-19 pandemic. Yet, even before the ...

A new mRNA cancer vaccine developed by Moderna has shown promising early results in clinical trials. The vaccine, mRNA-4359, ...

With the stock now more than cut in half from its 52-week high, the company recently laid out a plan for its business at its ...

A renowned art collection tucked in a much-adored park adds a newly accessible entranceway and below-grade galleries.

Fintel reports that on September 13, 2024, JP Morgan downgraded their outlook for Moderna (XTRA:0QF) from Neutral to Underweight. As of August 26, 2024, the average one-year price target for Moderna ...